Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Virginia Ciliento"'
Autor:
Alison E. Obr, Joseph J. Bulatowicz, Yun-Juan Chang, Virginia Ciliento, Alexander Lemenze, Krystopher Maingrette, Quan Shang, Emily J. Gallagher, Derek LeRoith, Teresa L. Wood
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionThe acquisition of a metastatic phenotype is the critical event that determines patient survival from breast cancer. Several receptor tyrosine kinases have functions both in promoting and inhibiting metastasis in breast tumors. Although t
Externí odkaz:
https://doaj.org/article/7b5e349e437a4cefac665b8cc2f837ff
Autor:
Virginia Ciliento, Emily J. Gallagher, Joseph J. Bulatowicz, Derek LeRoith, Krystopher Maingrette, Alison E. Obr, Teresa L. Wood, Alexander Lemenze, Quan Shang, Yung-Jun Chang
The acquisition of a metastatic phenotype is the critical event that determines patient survival from breast cancer. Several receptor tyrosine kinases have functions both in promoting and inhibiting metastasis in breast tumors. Although the insulin-l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d798218446f735e210abe85f6af5f16
https://doi.org/10.1101/2021.08.31.458283
https://doi.org/10.1101/2021.08.31.458283
Autor:
Krystopher Maingrette, Yun-Juan Chang, Joseph J. Bulatowicz, Virginia Ciliento, Teresa L. Wood, Alison E. Obr, Alexander Lemenze
Publikováno v:
Journal of the Endocrine Society
Although, IGF-1R historically has been considered a target for inhibition to treat breast cancer patients, recently, we have identified low levels of IGF-1R are associated with worse overall patient survival and basal-like, triple-negative breast can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7c2260d75bffc30ed0aa195dcc1ad64
http://europepmc.org/articles/PMC8265736
http://europepmc.org/articles/PMC8265736
Autor:
Joseph J. Bulatowicz, Virginia Ciliento, Alexander Lemenze, Alison E. Obr, Teresa L. Wood, Yun-Juan Chang, Krystopher Maingrette
Publikováno v:
Cancer Research. 81:2265-2265
Historically, IGF-1R has been considered a target for inhibition to treat breast cancer patients. We recently identified low levels of IGF-1R are associated with worse overall patient survival and basal-like, triple-negative breast cancer. Our findin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1228cc92427a383f657bf3a2846ecf3f
https://doi.org/10.1158/1538-7445.am2021-2265
https://doi.org/10.1158/1538-7445.am2021-2265